ACTA1 and neoplasm: Although CAF-targeted nanoparticles for remodeling the TME has indeed reduced levels of α-SMA expression and inhibited tumor growth(Alili et al., 2011), as α-SMA is also expressed in other cell types, targeting α-SMA+-CAF has not yet achieved ideal results.